Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
Wai Han Yiu(Queen Mary Hospital), Sydney Tang(Chinese University of Hong Kong)
Cited by 14
Related Papers
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
|The Lancet|2023|264
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
|The Lancet|2023|214
Mesenchymal Stem Cells Modulate Albumin-Induced Renal Tubular Inflammation and Fibrosis
|PLoS ONE|2014|80
Bradykinin and high glucose promote renal tubular inflammation
|Nephrology Dialysis Transplantation|2009|75